Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata

Journal of Antibiotics

Volumn 67, Issue 4, 2014, Pages 335-338

  Takemoto, Misao ^a,b   Kawamura, Yumi ^c   Hirohama, Mikako ^d,e,f   Yamaguchi, Yuki ^b   Handa, Hiroshi ^b   Saitoh, Hisato ^g   Nakao, Yoichi ^e   Kawada, Manabu ^h   Khalid, Khan ^d   Koshino, Hiroyuki ^d   Kimura, Ken Ichi ^c   Ito, Akihiro ^a,d   Yoshida, Minoru ^a,d,f  

^a Elements Chemistry Laboratory   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c IWATE UNIVERSITY   (Japan)

^d RIKEN   (Japan)

^e WASEDA UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^g KUMAMOTO UNIVERSITY   (Japan)

^h Microbial Chemistry Research Foundation   (Japan)

Author keywords

Davidia involucrata; Davidiin; ellagitannin; SUMOylation inhibitor

Indexed keywords

DAVIDIIN; ELLAGITANNIN; PROTEIN INHIBITOR; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; DAVIDIA INVOLUCRATA; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; FREEZE DRYING; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; SUMOYLATION; UBIQUITINATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CORNACEAE; DRUG DISCOVERY; HUMANS; HYDROLYZABLE TANNINS; JAPAN; MOLECULAR STRUCTURE; NEOPLASMS; OSMOLAR CONCENTRATION; PLANT EXTRACTS; PLANT LEAVES; SUMOYLATION; TANNINS;

EID: 84899730774     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2013.142     Document Type: Article

References (20)

1. Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382 (2004).
2. Dorval, V. & Fraser, P. E. SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694-706 (2007).
3. Boggio, R. & Chiocca, S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9, 430-436 (2006).
4. Alarcon-Vargas, D. & Ronai, Z. SUMO in cancer-wrestlers wanted. Cancer Biol. Ther. 1, 237-242 (2002).
5. Moschos, S. J. & Mo, Y. Y. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis. J. Mol. Histol. 37, 309-319 (2006).
6. Fukuda, I. et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem. Biol. 16, 133-140 (2009).
7. Fukuda, I. et al. Kerriamycin B inhibits protein SUMOylation. J. Antibiot. 62, 221-224 (2009).
8. Hirohama, M. et al. Spectomycin B1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E2. ACS Chem. Biol. 8, 2635-2642 (2013).
9. Kim, Y. S., Nagy, K., Keyser, S. & Schneekloth, J. S. Jr. An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation. Chem. Biol. 20, 604-613 (2013).
10. Uchimura, Y., Nakao, M. & Saitoh, H Generation of SUMO-1 modified proteins in E coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett. 564, 85-90 (2004).
11. Saitoh, N. et al. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Exp. Cell Res. 312, 1418-1430 (2006).
12. 4 and related conformations). J. Chem. Soc. Perkin Trans. 1 1, 2535-2545 (1982).
13. Hatano, T., Hattori, S., Ikeda, Y., Shingu, T. & Okuda, T. Gallotannins Having a 1, 5-Anhydro-D-glucitol Core and Some Ellagitannins from Acer Species. Chem. Pharm. Bull. 38, 1902-1905 (1990).
14. Yoshida, T et al. Tannins of Euphorbiaceous Plants. X. Antidesmin A, a New Dimeric Hydrolyzable Tannin from Antidesma pentandrum var. barbatum. Chem. Pharm. Bull 40, 338-342 (1992).
15. Kessler, J. D. et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353 (2012).
16. Zhu, M., Phillipson, J. D., Greengrass, P. M., Bowery, N. E. & Cai, Y. Plant polyphenols: biologically active compounds or non-selective binders to protein? Phytochemistry 44, 441-447 (1997).
17. Wang, Y. et al. A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2. Tu m o u r. B i o l. doi:10.1007/s13277-013-1025-3 (2013).
18. Riising, E. M., Boggio, R., Chiocca, S., Helin, K. & Pasini, D. The polycomb repressive complex 2 is a potential target of SUMO modifications. PLoS One 3, e2704 (2008).
19. Shin, Y. J. & Kim, J. H. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 7, e30393 (2012).
20. Kasai, Y., Michihata, N., Nishimura, H., Hirokane, T. & Yamada, H. Total synthesis of davidiin. Angew. Chem. Int. Ed. Engl. 51, 8026-8029 (2012).